Target intelligence / Profile preview

Clarin-1 (CLRN1) (CLRN1)

Target
CLRN1
Molecular classification
Tetraspanin-like protein, Four-transmembrane domain protein
01

Overview

Clarin-1 (CLRN1) is a four-transmembrane domain protein essential for the structural integrity and function of sensory hair cells in the inner ear and photoreceptor cells in the retina [UniProt P58418]. It is localized to the base of stereocilia and is believed to play a critical role in organizing the actin cytoskeleton and maintaining the stability of ribbon synapses, which are necessary for auditory and visual signal transmission [PubMed 21636704]. Mutations in the CLRN1 gene lead to Usher syndrome type 3A (USH3A), a rare genetic disorder characterized by progressive hearing loss and retinitis pigmentosa [NIH GARD]. Because the disease results from a loss of functional protein, therapeutic strategies focus on restoring the endogenous CLRN1 protein complex through gene replacement therapy. Current research utilizes adeno-associated virus (AAV) vectors to deliver a functional copy of the CLRN1 gene to the cochlea and retina, aiming to halt or slow the progression of sensory loss by re-establishing normal cellular architecture and synaptic function [PubMed 25713277].

Other names
USH3AUsher syndrome type-3A proteinClarin 1
02

Mechanism of action

Gene replacement therapy designed to restore endogenous protein expression and the functional protein complex in sensory cells.

03

Biological functions

Sensory perception of soundVisual perceptionSynaptic maintenanceCytoskeleton organization
04

Disease associations

Usher syndrome type 3ARetinitis pigmentosaSensorineural hearing loss
05

Safety considerations

Viral vector-induced inflammationSurgical risks of subretinal or intracochlear injectionPotential for overexpression-mediated cellular stress
06

Interacting drugs

AAV-CLRN1 (Investigational gene therapy)

2 more in the full profile.

07

Biomarkers

CLRN1 gene mutationElectroretinogram (ERG)Optical coherence tomography (OCT)Audiometric thresholds

Beyond the preview

Go deeper on Clarin-1 (CLRN1) (CLRN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clarin-1 (CLRN1) (CLRN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call